NOVNQ — NVN Liquidation Share News
0.000.00%
Last trade - 00:00- $0.02m
- -$4.60m
- $23.68m
Brief: Results From Novan’S Exploratory Studies Further Demonstrate Antimicrobial Effect Of Nitricil™ Platform Technology With Nvn4100 In Companion Animal Health
U.S. STOCKS ON THE MOVE-Vimeo, Moderna, Pieris Pharmaceuticals, Novan, Virgin Galactic
U.S. STOCKS ON THE MOVE-Novan, Lordstown Motors, Shake Shack, United Airlines
Novan Inc: Plunges on 1-for-10 reverse stock split
Brief: Novan Announces 1-For-10 Reverse Stock Split
Novan Inc reports results for the quarter ended in March - Earnings Summary
Brief: Novan Reports First Quarter 2021 Financial Results And Provides Corporate Update
Brief: Novan Reports Full Year 2020 Financial Results, Provides Corporate Update
Brief: Novan Completes Enrollment In B-SIMPLE4 Pivotal Phase 3 Study Of SB206 For Treatment Of Molluscum
Brief: Novan Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE-General Motors, Gilead Sciences, Aclaris, Facebook, ODP
Novan Inc: Rises on reaching 90% enrollment for skin infection treatment study
Brief: Novan Inc - B-Simple4 Pivotal Phase 3 Study In Molluscum Contagiosum Reaches 90% Enrollment With Topline Data Targeted For Q2 2021
Brief: Novan - Entered Into A Master Services Agreement With Catalent To Develop Intranasal Formulation Of Berdazimer Sodium For Covid-19 Program
Brief: Novan Inc Exceeds 60% Enrollment Pivotal Phase 3 Study of SB206 For Treatment Of Molluscum
Brief: Novan Receives Approval To Transfer To Nasdaq Capital Market
Brief: Novan Says Has Sufficient Capital To Fund Operations Through Q4 Of 2021
U.S. STOCKS ON THE MOVE-Twitter, Caterpillar, Wells Fargo, Restaurant Brands
U.S. STOCKS ON THE MOVE-Abercrombie & Fitch, Boeing, Wells Fargo, Goldman Sachs